Andrew M. Yeager, a University of
Arizona professor who is director of the Blood and Marrow Transplantation
Program at the Arizona Cancer Center. “But when one looks at a potentially lifesaving treatment, admittedly expensive, and we have data to support efficacy, cuts like this are shortsighted and sad.”
State Medicaid officials said they recommended discontinuing some transplants only after assessing the success rates for previous patients.